How Freudenberg Built a Startup-Style Innovation Engine for Emerging Tech
Technovation with Peter High (CIO, CTO, CDO, CXO Interviews)Show Notes
How does a 177-year-old industrial company maintain startup speed while preparing for technologies that may not mature for another decade?
In this episode of Technovation, Peter High speaks with Vishwanath Hegadekatte, Director of Innovation at Freudenberg Technology Innovation (FTI), about building an internal innovation engine designed to identify, test, and scale emerging technologies across a global manufacturing enterprise. Vishwanath explains how Freudenberg combines strategic foresight, AI-driven research, external partnerships, and startup-style experimentation to help its business units prepare for opportunities years before they become mainstream. The conversation explores humanoid robotics, agentic AI, advanced materials, and the organizational structures required to turn innovation into measurable business impact.
This episode is presented by Celonis — Give AI the context it needs. Learn more at celonis.com/technovation
More from Technovation with Peter High (CIO, CTO, CDO, CXO Interviews)
AI layered onto a broken process doesn’t fix the process; it just runs it faster. Prakash Kota spent his first 18 months at UKG consolidating two legacy companies into unified CRM, ERP, and data systems before any AI conversation began. Now, as Chief Transformation Officer, he is shifting the question from “what tools can we deploy?” to “what outcome are we trying to reach?” That discipline extends to the customer funnel, where AI-assembled signals travel with a prospect through every handoff, and to sales reps, where an autonomous assistant pushes pre-meeting briefs before a rep has to ask, reclaiming the 40–50% of call-prep time currently spent on research.
The binding constraint on AI adoption is not access to tools. It is the organizational fear and mindset shift required to reimagine work entirely.
Healthcare has accumulated friction that patients have come to accept as normal. Novant Health’s Chief AI Officer is systematically dismantling it.
Most generative AI programs stall at the pilot stage. Zoetis reached 95% computer-based colleague adoption.
The next generation of technology giants may not be built in software. They may be built in factories.